{
    "name": "fresh frozen plasma",
    "comment": "Blood Component",
    "other_names": [
        "FFP",
        "Octaplas"
    ],
    "classes": [
        "Blood Components"
    ],
    "source": "https://reference.medscape.com/drug/ffp-octaplas-fresh-frozen-plasma-999499",
    "pregnancy": null,
    "lactation": null,
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "IgA deficiency",
                "Severe protein S deficiency",
                "History of hypersensitivity to fresh frozen plasma (FFP) or to plasma-derived products including any plasma protein",
                "History of hypersensitivity reaction to Octaplas",
                "FFP should not be used solely for volume expansion, or to \"correct\" a mildly prolonged PT or PTT without active bleeding; patients may have a mildly prolonged PT or PTT and yet have hemostatically stable levels of coagulation factors",
                "Plasma should not be given for replacement of isolated factor or specific protein deficiencies if the appropriate factor concentrates are available",
                "Plasma should not be given for vitamin K deficiency or warfarin reversal if correction can safely be achieved using vitamin K supplementation",
                "If a transfusion reaction is suspected, the transfusion should be stopped, the patient assessed and stabilized, the blood bank notified, and a transfusion reaction investigation initiated",
                "Many blood banks utilize P24 and/or thawed plasma interchangeably with FFP; if FFP is specifically needed, it is advisable to inform your institutionâ€™s blood bank at the time of request to ensure appropriate product transfusion",
                "Liquid plasma (please see pharmacology for description) may have a significant amount of viable lymphocytes and should be irradiated if the patient is at increased risk of TA-GVHD (see the irradiated blood product monograph)",
                "All transfusions must be given via blood administration sets containing 170- to 260-micron filters or 20- to 40-micron microaggregate filters unless transfusion is given via a bedside leukocyte reduction filter; no other medications or fluids other than normal saline should be simultaneously given through the same line without prior consultation with the medical director of the blood bank",
                "Transfusion reaction may occur with ABO mismatch; administration of this product must be based on ABO-blood group compatibility; patients should be monitored for signs of a transfusion reaction including vitals pre, during, and post-transfusion; plasma components contain a significant amount of antibodies against the ABO blood group antigens and ABO compatible plasma must be used",
                "High infusion rates can induce hypervolemia with consequent pulmonary edema or cardiac failure; monitor patients for signs and symptoms of pulmonary edema or heart failure and institute appropriate management",
                "Excessive bleeding due to hyperfibrinolysis can occur due to low levels of alpha2-antiplasmin (ie, plasmin inhibitor); monitor for signs of excessive bleeding in patients undergoing liver transplantation",
                "Thrombosis can occur due to low levels of Protein S; monitor for signs and symptoms of thrombosis in patients at risk",
                "This product is made from human plasma, it may carry a risk of transmitting infectious agents (eg, viruses, vCJD agent); undergoes solvent-detergent purification",
                "Consult with blood bank medical director or hematologist if you have questions regarding special transfusion requirements",
                "Do not inject drugs containing calcium in the same IV line (precipitant may occur)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nervous system",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "paresthesia",
            "percent": null
        },
        {
            "name": "Gastrointestinal",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "Hemolytic Transfusion Reactions",
            "percent": null
        },
        {
            "name": "Febrile Non",
            "percent": null
        },
        {
            "name": "Hemolytic Reactions",
            "percent": null
        },
        {
            "name": "Allergic Reactions ranging from urticaria to anaphylaxis",
            "percent": null
        },
        {
            "name": "Septic Reactions",
            "percent": null
        },
        {
            "name": "Transfusion Related Acute Lung Injury",
            "percent": null
        },
        {
            "name": "TRALI",
            "percent": null
        },
        {
            "name": "Circulatory Overload",
            "percent": null
        },
        {
            "name": "Transfusion Associated Graft Versus Host Disease",
            "percent": null
        },
        {
            "name": "Post",
            "percent": null
        },
        {
            "name": "transfusion Purpura",
            "percent": null
        },
        {
            "name": "Blood system disorders",
            "percent": null
        },
        {
            "name": "Hyperfibrinolysis",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions including anaphylactoid and allergic type of reactions",
            "percent": null
        },
        {
            "name": "Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "Alkalosis",
            "percent": null
        },
        {
            "name": "Cardiovascular disorders",
            "percent": null
        },
        {
            "name": "Cardiac arrest",
            "percent": null
        },
        {
            "name": "circulatory overload",
            "percent": null
        },
        {
            "name": "thromboembolism",
            "percent": null
        },
        {
            "name": "tachycardia",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Respiratory arrest or failure",
            "percent": null
        },
        {
            "name": "bronchospasm",
            "percent": null
        },
        {
            "name": "pulmonary edema",
            "percent": null
        },
        {
            "name": "dyspnea",
            "percent": null
        },
        {
            "name": "tachypnea",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "erythema",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Fever and",
            "percent": null
        },
        {
            "name": "or chills",
            "percent": null
        },
        {
            "name": "chest discomfort or pain",
            "percent": null
        },
        {
            "name": "Investigations",
            "percent": null
        },
        {
            "name": "Seroconversions",
            "percent": null
        },
        {
            "name": "passive transfer of antibodies",
            "percent": null
        },
        {
            "name": "Injury",
            "percent": null
        },
        {
            "name": "poisoning and procedural complications",
            "percent": null
        },
        {
            "name": "Citrate toxicity",
            "percent": null
        }
    ]
}